Addex Therapeutics (ADXN) Institutional Ownership $7.60 +0.17 (+2.34%) As of 04/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Addex Therapeutics (NASDAQ:ADXN)CurrentInstitutional OwnershipPercentage16.14%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$141.41KNumber ofInstitutional Sellers(last 12 months)0 Get ADXN Insider Trade Alerts Want to know when executives and insiders are buying or selling Addex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADXN Institutional Buying and Selling by Quarter Addex Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/7/2025 GAMMA Investing LLC8,757$64K0.0%+766.2%0.826% 2/17/2025Citadel Advisors LLC12,079$85K0.0%N/A1.140% 2/13/2024Armistice Capital LLC43,000$260K0.0%-92.0%4.343% 11/15/2023Armistice Capital LLC537,000$206K0.0%+103.4%65.328% 5/1/2023Virtu Financial LLC42,912$41K0.0%+203.8%0.334% 2/14/2023Susquehanna International Group LLP72,142$45K0.0%N/A0.561% 2/10/2023NEA Management Company LLC1,080,000$113K0.0%-80.9%8.398% 11/14/2022Armistice Capital LLC320,000$256K0.0%+26.5%2.941% 11/14/2022NEA Management Company LLC5,648,690$830K0.0%+500.0%51.923% 8/5/2022OLD Mission Capital LLC31,134$36K0.0%N/A0.286% 8/12/2021New Leaf Venture Partners L.L.C.50,000$478K0.1%N/A0.609% 8/2/2021NEA Management Company LLC180,000$17.21M0.2%N/A2.192% 5/21/2021Citadel Advisors LLC11,604$121K0.0%N/A0.141% 5/18/2021Citadel Advisors LLC11,604$121K0.0%N/A0.212% 5/12/2021UBS Group AG2,520$26K0.0%+2,420.0%0.046% (Data available from 1/1/2016 forward) ADXN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADXN shares? During the previous two years, the following institutional investors and hedge funds held shares of Addex Therapeutics shares: Armistice Capital LLC ($260K), Citadel Advisors LLC ($85K), and GAMMA Investing LLC ($64K), Virtu Financial LLC ($41K).Learn more on ADXN's institutional investors. What percentage of Addex Therapeutics stock is owned by institutional investors? 16.14% of Addex Therapeutics stock is owned by institutional investors. Learn more on ADXN's institutional investor holdings. Which institutional investors have been buying Addex Therapeutics stock? The following institutional investors have purchased Addex Therapeutics stock in the last 24 months: Armistice Capital LLC ($273K), Virtu Financial LLC ($28.79K), Citadel Advisors LLC ($12.08K), and GAMMA Investing LLC ($7.75K). How much institutional buying is happening at Addex Therapeutics? Institutional investors have bought a total of 321,614 shares in the last 24 months. This purchase volume represents approximately $2.78M in transactions. Which Addex Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Addex Therapeutics stock in the last 24 months: Armistice Capital LLC ($494K). How much institutional selling is happening at Addex Therapeutics? Institutional investors have sold a total of 494,000 shares in the last 24 months. This volume of shares sold represents approximately $2.99M in transactions. Related Companies Cadrenal Therapeutics Major Shareholders Allakos Major Shareholders Alterity Therapeutics Major Shareholders OS Therapies Major Shareholders Barinthus Biotherapeutics Major Shareholders Aligos Therapeutics Major Shareholders Pluri Major Shareholders ALX Oncology Major Shareholders VYNE Therapeutics Major Shareholders Clene Major Shareholders This page (NASDAQ:ADXN) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADXN Stock Free ADXN Stock Alerts